Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2

The production of specific neutralizing antibodies by individuals is thought to be the best option for reducing the number of patients with severe COVID-19, which is the reason why multiple vaccines are currently being administered worldwide. We aimed to explore the effect of revaccination with BCG,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Espiridión Ramos-Martinez, Ramcés Falfán-Valencia, Gloria Pérez-Rubio, Warrison Athanasio Andrade, Jorge Rojas-Serrano, Enrique Ambrocio-Ortiz, Dennisse S. Galicia-Álvarez, Isaac Bárcenas-Montiel, Andrea Velasco-Medina, Guillermo Velázquez-Sámano
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
BCG
Acceso en línea:https://doaj.org/article/e0180518a2dc4017a7eec43451a048f3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e0180518a2dc4017a7eec43451a048f3
record_format dspace
spelling oai:doaj.org-article:e0180518a2dc4017a7eec43451a048f32021-11-25T17:12:25ZEffect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-210.3390/cells101131792073-4409https://doaj.org/article/e0180518a2dc4017a7eec43451a048f32021-11-01T00:00:00Zhttps://www.mdpi.com/2073-4409/10/11/3179https://doaj.org/toc/2073-4409The production of specific neutralizing antibodies by individuals is thought to be the best option for reducing the number of patients with severe COVID-19, which is the reason why multiple vaccines are currently being administered worldwide. We aimed to explore the effect of revaccination with BCG, on the response to a subsequent anti-SARS-CoV-2 vaccine, in persons occupationally exposed to COVID-19 patients. Two groups of 30 randomized participants were selected: one group received a BCG revaccination, and the other group received a placebo. Subsequently, both groups were vaccinated against SARS-CoV-2. After each round of vaccination, the serum concentration of Th1/Th2 cytokines was determined. At the end of the protocol, neutralizing antibodies were determined and the HLA-DRB loci were genotyped. The participants from the BCG group and anti-SARS-CoV-2 vaccine group had increased serum cytokine concentrations (i.e., IL-1β, IL-4, IL-6, IL-12p70, IL-13, IL-18, GM-CSF, INF-γ, and TNF-α) and higher neutralizing antibody titers, compared to the group with Placebo–anti-SARS-CoV-2. Twelve HLA-DRB1 alleles were identified in the Placebo–anti-SARS-CoV-2 group, and only nine in the group revaccinated with BCG. The DRB1*04 allele exhibited increased frequency in the Placebo–anti-SARS-CoV-2 group; however, no confounding effects were found with this allele. We conclude that revaccination with BCG synergizes with subsequent vaccination against SARS-CoV-2 in occupationally exposed personnel.Espiridión Ramos-MartinezRamcés Falfán-ValenciaGloria Pérez-RubioWarrison Athanasio AndradeJorge Rojas-SerranoEnrique Ambrocio-OrtizDennisse S. Galicia-ÁlvarezIsaac Bárcenas-MontielAndrea Velasco-MedinaGuillermo Velázquez-SámanoMDPI AGarticleSARS-CoV-2COVID-19BCGvaccinationneutralizing antibodiesBiology (General)QH301-705.5ENCells, Vol 10, Iss 3179, p 3179 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS-CoV-2
COVID-19
BCG
vaccination
neutralizing antibodies
Biology (General)
QH301-705.5
spellingShingle SARS-CoV-2
COVID-19
BCG
vaccination
neutralizing antibodies
Biology (General)
QH301-705.5
Espiridión Ramos-Martinez
Ramcés Falfán-Valencia
Gloria Pérez-Rubio
Warrison Athanasio Andrade
Jorge Rojas-Serrano
Enrique Ambrocio-Ortiz
Dennisse S. Galicia-Álvarez
Isaac Bárcenas-Montiel
Andrea Velasco-Medina
Guillermo Velázquez-Sámano
Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
description The production of specific neutralizing antibodies by individuals is thought to be the best option for reducing the number of patients with severe COVID-19, which is the reason why multiple vaccines are currently being administered worldwide. We aimed to explore the effect of revaccination with BCG, on the response to a subsequent anti-SARS-CoV-2 vaccine, in persons occupationally exposed to COVID-19 patients. Two groups of 30 randomized participants were selected: one group received a BCG revaccination, and the other group received a placebo. Subsequently, both groups were vaccinated against SARS-CoV-2. After each round of vaccination, the serum concentration of Th1/Th2 cytokines was determined. At the end of the protocol, neutralizing antibodies were determined and the HLA-DRB loci were genotyped. The participants from the BCG group and anti-SARS-CoV-2 vaccine group had increased serum cytokine concentrations (i.e., IL-1β, IL-4, IL-6, IL-12p70, IL-13, IL-18, GM-CSF, INF-γ, and TNF-α) and higher neutralizing antibody titers, compared to the group with Placebo–anti-SARS-CoV-2. Twelve HLA-DRB1 alleles were identified in the Placebo–anti-SARS-CoV-2 group, and only nine in the group revaccinated with BCG. The DRB1*04 allele exhibited increased frequency in the Placebo–anti-SARS-CoV-2 group; however, no confounding effects were found with this allele. We conclude that revaccination with BCG synergizes with subsequent vaccination against SARS-CoV-2 in occupationally exposed personnel.
format article
author Espiridión Ramos-Martinez
Ramcés Falfán-Valencia
Gloria Pérez-Rubio
Warrison Athanasio Andrade
Jorge Rojas-Serrano
Enrique Ambrocio-Ortiz
Dennisse S. Galicia-Álvarez
Isaac Bárcenas-Montiel
Andrea Velasco-Medina
Guillermo Velázquez-Sámano
author_facet Espiridión Ramos-Martinez
Ramcés Falfán-Valencia
Gloria Pérez-Rubio
Warrison Athanasio Andrade
Jorge Rojas-Serrano
Enrique Ambrocio-Ortiz
Dennisse S. Galicia-Álvarez
Isaac Bárcenas-Montiel
Andrea Velasco-Medina
Guillermo Velázquez-Sámano
author_sort Espiridión Ramos-Martinez
title Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
title_short Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
title_full Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
title_fullStr Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
title_full_unstemmed Effect of BCG Revaccination on Occupationally Exposed Medical Personnel Vaccinated against SARS-CoV-2
title_sort effect of bcg revaccination on occupationally exposed medical personnel vaccinated against sars-cov-2
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/e0180518a2dc4017a7eec43451a048f3
work_keys_str_mv AT espiridionramosmartinez effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT ramcesfalfanvalencia effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT gloriaperezrubio effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT warrisonathanasioandrade effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT jorgerojasserrano effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT enriqueambrocioortiz effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT dennissesgaliciaalvarez effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT isaacbarcenasmontiel effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT andreavelascomedina effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
AT guillermovelazquezsamano effectofbcgrevaccinationonoccupationallyexposedmedicalpersonnelvaccinatedagainstsarscov2
_version_ 1718412684494372864